tirzepatide causing blindness Comparative ocular outcomes of versus other anti-obesity medications in people with obesity Acute onset of neovascular age-related

For decades, Aspirin has been the reference pharmacologic agent in colorectal cancer prevention

Low-dose interleukin-2 therapy in active systemic lupus erythematosus (LUPIL-2): a multicentre, double-blind, randomised and placebo-controlled phase II trial

Between 2005 approval and the 2017 approval of semaglutide, 5 other GLP-1 receptor agonists received approval and came to market, including Novo Nordisks liraglutide (Victoza), which received approval in January 2010

Tirzepatide results timeline What the trials measured week by week

The International Diabetes Federation (IDF) reported that in 2021, diabetes affected 8.8% of adults globally, with men at a higher risk (9.6%) than women (9.0%)